Archives

Apnimed Announces Three Oral Presentations and a Late-breaking Poster at the American Thoracic Society (ATS) 2026 International Conference

B CAMBRIDGE, Mass., May 11, 2026 /PRNewswire/ — Apnimed, Inc., a late stage clinical pharmaceutical company dedicated to the discovery, development, and commercialization of novel oral… Login to continue reading Login…

Read MoreApnimed Announces Three Oral Presentations and a Late-breaking Poster at the American Thoracic Society (ATS) 2026 International Conference

HealthCentral Launches Drops, the First Vertical Video App Built for People Living with Chronic, Serious, and Rare Conditions

B New social network combines vetted health and clinician creators, medically reviewed content, and condition-specific feeds, built for how people actually seek health information today… Login to continue reading Login…

Read MoreHealthCentral Launches Drops, the First Vertical Video App Built for People Living with Chronic, Serious, and Rare Conditions